Sanofi India Limited (SANOFI) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Sanofi India Limited stock ₹2,214, price ₹3,282, that is 32.5% below the price, quality 88 out of 100. Rating: overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Sanofi India Limited
SANOFI · NSEExpensive (fair value 33% below the price) and falling price, but strong company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ₹2,413 – ₹7,083 · fair‑value band ₹1,650 – ₹2,798 · the ₹3,282 price screens above the ₹2,214 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Sanofi India is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
Show moreShow less
The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors.
It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.
Stock analysis
Sanofi India Limited (SANOFI) currently trades at ₹3,282, while our model-based Fair Value estimate is ₹2,214, 33% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹2,802 per share, and 1 of the 24 models we run sit above the ₹3,282 price.
Bear case: the Economic Profit group reads lowest at ₹1,014, and 23 of the 24 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹1,650 (bear) to ₹2,798 (bull), the price of ₹3,282 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 88/100 (high quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Sanofi India Limited reported revenue of ₹18.4B in FY2025 versus ₹29.6B in FY2021, a compound −11.2%/yr. Reported net income was ₹3.3B in FY2025, compounding −23.3%/yr from FY2021.
Key figures
Market cap ₹75.6B (≈ $802M) Small · P/E ratio 20.7 · P/S ratio 4.15 · EPS (TTM) ₹158.27 · Dividend yield 3.7% · Net margin 20.0% · Return on equity 40.3% · Return on assets (EBIT) 43.5% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 92 out of 100 (medium confidence).
What moves the price
The share trades about 28% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at −33%, SANOFI screens richer than that median.
Fair Value models
All 24 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
SANOFI screens overvalued: fair value 33% below the price. Compare with Eli Lilly and Company →
Compare Sanofi India Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - General · 74 stocks
Valuation Multiplesvs Drug Manufacturers - General median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Quality Score by industry
- Return on equity by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - General stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Bristol-Myers Squibb Company BMY | $63.43 | $75.91 | +20% | vs SANOFI |
| Amgen Inc AMGN | $465.67 | $512.24 | +10% | vs SANOFI |
| Gilead Sciences, Inc GILD | $168.08 | $184.89 | +10% | vs SANOFI |
| Novartis AG NOVN | CHF 135.76 | CHF 122.91 | −9% | vs SANOFI |
| AbbVie Inc ABBV | $295.03 | $259.62 | −12% | vs SANOFI |
| Merck & Co MRK | $147.76 | $129.26 | −13% | vs SANOFI |
| Pfizer Inc PFE | $28.89 | $24.87 | −14% | vs SANOFI |
| Roche Holding RO | CHF 414.20 | CHF 326.56 | −21% | vs SANOFI |
| Johnson & Johnson, JNJ | $285.75 | $169.03 | −41% | vs SANOFI |
| Eli Lilly and Company LLY | $1,444 | $749.92 | −48% | vs SANOFI |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Sanofi India Limited (SANOFI) overvalued or undervalued?
What is the fair value of SANOFI?
What is the quality score of SANOFI?
What is the price target for Sanofi India Limited (SANOFI)?
What is the Sanofi India Limited stock forecast for 2026?
What is the revenue of Sanofi India Limited (SANOFI)?
Does Sanofi India Limited pay a dividend?
How much is the dividend of Sanofi India Limited (SANOFI) and when is the ex-dividend date?
What growth is priced into Sanofi India Limited (SANOFI)?
What discount rate (WACC) does the fair value of SANOFI use?
What is a reverse DCF?
How much growth has Sanofi India Limited (SANOFI) delivered so far?
How fast is the sector of Sanofi India Limited (SANOFI) growing?
What is the free cash flow yield of Sanofi India Limited (SANOFI)?
What is the intrinsic value of Sanofi India Limited (SANOFI)?
Is Sanofi India Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of SANOFI?
How much is Sanofi India Limited worth?
What do the bullish and bearish scenarios say about SANOFI?
What is the P/E ratio of SANOFI?
How solid is the balance sheet of Sanofi India Limited (SANOFI)?
How far is SANOFI from its 52-week high?
Which stocks are comparable to Sanofi India Limited?
Is Sanofi India Limited stock attractive at the current price?
How is the fair value of SANOFI calculated?
Is it still worth investing in stocks now?
What is the share price of Sanofi India Limited (SANOFI)?
What should I pay attention to with Sanofi India Limited right now?
Where does the earnings growth of Sanofi India Limited (SANOFI) come from?
Key figures of Sanofi India Limited
How large is the market capitalisation of Sanofi India Limited (SANOFI)?
What is the P/S ratio of Sanofi India Limited (SANOFI)?
What are the earnings per share of Sanofi India Limited (SANOFI)?
What is the dividend yield of Sanofi India Limited (SANOFI)?
What is the net margin of Sanofi India Limited (SANOFI)?
What is the return on equity of Sanofi India Limited (SANOFI)?
What is the EBIT return on assets of Sanofi India Limited (SANOFI)?
What is the operating margin of Sanofi India Limited (SANOFI)?
How fast is revenue growing at Sanofi India Limited (SANOFI)?
How fast are earnings growing at Sanofi India Limited (SANOFI)?
How much net cash does Sanofi India Limited (SANOFI) hold?
Watch Sanofi India Limited in the live analysis
One click puts Sanofi India Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.